No Data
No Data
Express News | Adaptimmune Therapeutics PLC : Jonestrading Raises Target Price to $2.50 From $2
JonesTrading Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Raises Target Price to $2.5
JonesTrading analyst Soumit Roy maintains $Adaptimmune Therapeutics(ADAP.US)$ with a buy rating, and adjusts the target price from $2 to $2.5.According to TipRanks data, the analyst has a success
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
European equities traded in the US as American depositary receipts were moving moderately lower late Thursday morning, declining 0.72% to 1,423.26 on the S&P Europe Select ADR Index.From continental
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
European equities traded in the US as American depositary receipts opened the week trending lower late Monday morning, declining 0.37% to 1,463.52 on the S&P Europe Select ADR Index.From continental
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.From continental
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading
European equities traded in the US as American depositary receipts started the week off on a flat note late Monday morning, nudging 0.002% higher to 1,452.10 on the S&P Europe Select ADR Index.From co